<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Cevins C</submitter><funding>Agence Nationale de la Recherche</funding><funding>Université de Paris</funding><funding>Institut National de la Santé et de la Recherche Médicale</funding><funding>Sanofi US</funding><funding>Fondation pour la Recherche Médicale</funding><funding>Fondation Bettencourt Schueller</funding><pagination>101333</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10772457</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(12)</volume><pubmed_abstract>Gain-of-function mutations in stimulator of interferon gene 1 (STING1) result in STING-associated vasculopathy with onset in infancy (SAVI), a severe autoinflammatory disease. Although elevated type I interferon (IFN) production is thought to be the leading cause of the symptoms observed in patients, STING can induce a set of pathways, which have roles in the onset and severity of SAVI and remain to be elucidated. To this end, we performed a multi-omics comparative analysis of peripheral blood mononuclear cells (PBMCs) and plasma from SAVI patients and healthy controls, combined with a dataset of healthy PBMCs treated with IFN-β. Our data reveal a subset of disease-associated monocyte, expressing elevated CCL3, CCL4, and IL-6, as well as a strong integrated stress response, which we sugges</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>Single-cell RNA-sequencing of PBMCs from SAVI patients reveals disease-associated monocytes with elevated integrated stress response.</pubmed_title><pmcid>PMC10772457</pmcid><funding_grant_id>ANR-18-RHUS-0010</funding_grant_id><funding_grant_id>EQU202103012670</funding_grant_id><funding_grant_id>ANR-10-IAHU-01</funding_grant_id><pubmed_authors>Hoareau B</pubmed_authors><pubmed_authors>Perot BP</pubmed_authors><pubmed_authors>Batignes M</pubmed_authors><pubmed_authors>Quartier P</pubmed_authors><pubmed_authors>Garcia-Paredes V</pubmed_authors><pubmed_authors>Pierre P</pubmed_authors><pubmed_authors>Alain F</pubmed_authors><pubmed_authors>Menager MM</pubmed_authors><pubmed_authors>Parisot M</pubmed_authors><pubmed_authors>Riller Q</pubmed_authors><pubmed_authors>Rieux-Laucat F</pubmed_authors><pubmed_authors>Carbone F</pubmed_authors><pubmed_authors>Boussard C</pubmed_authors><pubmed_authors>Auge F</pubmed_authors><pubmed_authors>Delage L</pubmed_authors><pubmed_authors>Meunier C</pubmed_authors><pubmed_authors>Fremond ML</pubmed_authors><pubmed_authors>Didier M</pubmed_authors><pubmed_authors>Guillemot JC</pubmed_authors><pubmed_authors>Remaury A</pubmed_authors><pubmed_authors>Nal B</pubmed_authors><pubmed_authors>Canard L</pubmed_authors><pubmed_authors>de Cevins C</pubmed_authors><pubmed_authors>Neven B</pubmed_authors><pubmed_authors>Zarhrate M</pubmed_authors><pubmed_authors>Masson C</pubmed_authors><pubmed_authors>Fali T</pubmed_authors><pubmed_authors>Galliot L</pubmed_authors><pubmed_authors>Belot A</pubmed_authors><pubmed_authors>Boldina G</pubmed_authors><pubmed_authors>Sorin B</pubmed_authors><pubmed_authors>Crickx E</pubmed_authors><pubmed_authors>Bader-Meunier B</pubmed_authors><pubmed_authors>Luka M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell RNA-sequencing of PBMCs from SAVI patients reveals disease-associated monocytes with elevated integrated stress response.</name><description>Gain-of-function mutations in stimulator of interferon gene 1 (STING1) result in STING-associated vasculopathy with onset in infancy (SAVI), a severe autoinflammatory disease. Although elevated type I interferon (IFN) production is thought to be the leading cause of the symptoms observed in patients, STING can induce a set of pathways, which have roles in the onset and severity of SAVI and remain to be elucidated. To this end, we performed a multi-omics comparative analysis of peripheral blood mononuclear cells (PBMCs) and plasma from SAVI patients and healthy controls, combined with a dataset of healthy PBMCs treated with IFN-β. Our data reveal a subset of disease-associated monocyte, expressing elevated CCL3, CCL4, and IL-6, as well as a strong integrated stress response, which we sugges</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2026-07-15T10:39:36.025Z</modification><creation>2025-04-06T13:11:52.205Z</creation></dates><accession>S-EPMC10772457</accession><cross_references><pubmed>38118407</pubmed><doi>10.1016/j.xcrm.2023.101333</doi></cross_references></HashMap>